v3.26.1
Impairment
6 Months Ended
Jun. 30, 2026
Disclosure of impairment loss and reversal of impairment loss [abstract]  
Impairment 5. Impairment
2026
2025
Six months ended 30 June
Pre-tax
amount
US$m
Taxation
US$m
Non-
controlling
interest
US$m
Net amount
US$m
Pre-tax
amount
US$m
Other operations – RTITQO
(122)
Aluminium – Porto Trombetas (MRN)
15
15
Net impairment reversals/(charges)
15
15
(122)
Allocated as:
Property, plant and equipment
(122)
Share of profit after tax of equity accounted units
15
Net impairment reversals/(charges)
15
(122)
Other operations - Rio Tinto Iron and Titanium Quebec Operations (RTITQO) and QIT
Madagascar Minerals (QMM)
In 2025, we progressed a business transformation at RTITQO in response to challenging market
conditions for our products at the Sorel site, including TiO2 and metallics. This transformation,
which includes the adjustment of the business footprint to projected demand, was expected to
take up to 24 months to complete its core components. At 30 June 2025, we identified these
conditions as an impairment trigger and performed an impairment test for the cash-generating unit
which comprises the mines and processing facilities at RTITQO (in Canada) and QMM (in
Madagascar).
We expected the transformation program to result in significant improvements in operating costs,
including opportunities to reduce carbon emissions and therefore carbon costs. However, for the
purpose of performing the impairment test, risk adjustments were applied to reduce the forecast
cash flows to reflect a market participant perspective that the value of the projected initiates may
not fully deliver the expected benefit.
Using a fair value less cost of disposal methodology and discounting real-terms post-tax cash
flows at an effective rate of 7.6% we determined the recoverable amount to be US$1,780 million.
This resulted in a pre-tax impairment charge during the six months ended 30 June 2025 of
US$122 million  (post-tax US$86 million) and was allocated to property, plant and equipment in
Canada.
During 2026, market conditions have remained challenging and therefore we have tested the
assets again for impairment. The testing parameters were not materially different and no
impairment charge or impairment reversal was identified.